Canadian Sec - Free Realtime Quote CAD

RIV Capital Inc. (RIV.CN)

Compare
0.1900 +0.0050 (+2.70%)
As of 11:50 a.m. EDT. Market Open.
Loading Chart for RIV.CN
DELL
  • Previous Close 0.1850
  • Open 0.1900
  • Bid --
  • Ask 0.1900 x --
  • Day's Range 0.1850 - 0.1950
  • 52 Week Range 0.0800 - 0.2300
  • Volume 38,715
  • Avg. Volume 38,054
  • Market Cap (intraday) 25.935M
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4600
  • Earnings Date Nov 27, 2024 - Dec 2, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to CA$40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and production-linked royalties. RIV Capital Inc. was founded on 2017 and is based in Toronto, Canada.

www.rivcapital.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Recent News: RIV.CN

View More

Performance Overview: RIV.CN

Trailing total returns as of 2024-10-31, which may include dividends or other distributions. Benchmark is

.

YTD Return

RIV.CN
80.95%
S&P/TSX Composite index
15.21%

1-Year Return

RIV.CN
35.71%
S&P/TSX Composite index
28.05%

3-Year Return

RIV.CN
88.13%
S&P/TSX Composite index
14.78%

5-Year Return

RIV.CN
88.41%
S&P/TSX Composite index
46.33%

Compare To: RIV.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RIV.CN

View More

Valuation Measures

As of 2024-10-30
  • Market Cap

    25.25M

  • Enterprise Value

    121.81M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.80

  • Price/Book (mrq)

    0.63

  • Enterprise Value/Revenue

    12.36

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    9.81M

  • Net Income Avi to Common (ttm)

    -65.68M

  • Diluted EPS (ttm)

    -0.4600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    57.7M

  • Total Debt/Equity (mrq)

    440.54%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: RIV.CN

View More

Revenue vs. Earnings

Revenue 3.79M
Earnings -8.28M
 

Analyst Price Targets

 

People Also Watch